Wednesday, November 01, 2006
Still Waiting for Personalized Medicine
Pharmacogenomics promises to let doctors choose drugs and dosages based on tests of your genetic profile. But just try taking a test.
By Emily Singer
Nausea, fatigue, dizziness, dry mouth, insomnia. For people like me, who seem susceptible to every side effect possible, the tiny type on ads for new drugs is required reading. NyQuil puts me into a half-conscious delirium. Codeine makes me throw up. And back in college, when my doctor prescribed Wellbutrin to help me quit smoking, I experienced blurred vision and the worst headaches of my life.
| Subscribe to the Technology Review Magazine
To view this article, you must have a paid subscription to Technology Review (print or digital edition) OR you can purchase credits to view individual articles. We have several options for content access:
Technology Review does more than tell you about what you can expect to see next. We explain it to you, in graphic, riveting detail. If it’s relevant to technology and the future, you’ll learn about it first in Technology Review. Well before the mainstream press wakes up to a technology breakthrough, Technology Review will have made it available to you. But we don’t just report—we analyze. You get in-depth coverage that’s authoritative, reliable, and universally respected.
|
|
|
Massachusetts Institute of Technology